Clovis Oncology Inc reports results for the quarter ended in June - Earnings Summary

Clovis Oncology

04/08/2021 15:01

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly adjusted
loss of 61 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 56 cents per share.
* Revenue fell 7.7% to $36.82 million from a year ago;  analysts
expected $41.34 million. 
* Clovis Oncology Inc's reported EPS for the quarter was a loss
of 61 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.3% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Clovis Oncology Inc shares had fallen by 16.2% this
quarter and gained 1.3% so far this year.
* The company reported a quarterly loss of $66.45 million.
* Wall Street's median 12-month price target for Clovis Oncology
Inc is $5.75 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 3 "sell" or "strong sell." 
This summary was machine generated August 4 at 02:01 p.m.  ​All
figures in US dollars unless otherwise stated